Danske Bank
WST icon

Danske Bank’s West Pharmaceutical WST Stock Holding History

Danske Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13M Buy
35,036
+2,607
+8% +$920K 0.03% 408
2026
Q2 		$11.6M Buy
32,429
+1,181
+4% +$361K 0.02% 431
2026
Q1 		$7.83M Sell
31,248
-2,269
-7% -$565K 0.02% 476
2025
Q4 		$9.22M Buy
33,517
+1,654
+5% +$452K 0.02% 454
2025
Q3 		$8.36M Buy
31,863
+1,754
+6% +$426K 0.02% 461
2025
Q2 		$6.59M Buy
30,109
+2,076
+7% +$444K 0.02% 497
2025
Q1 		$6.28M Sell
28,033
-7,718
-22% -$2.13M 0.02% 496
2024
Q4 		$11.7M Buy
35,751
+4,227
+13% +$1.33M 0.04% 384
2024
Q3 		$9.46M Buy
31,524
+2,781
+10% +$852K 0.03% 400
2024
Q2 		$9.47M Sell
28,743
-1,951
-6% -$689K 0.03% 381
2024
Q1 		$12.1M Buy
+30,694
New +$11.4M 0.04% 382

Other funds holding WST

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Danske Bank's WST Position: Q3 2026 in Review

Danske Bank increased its West Pharmaceutical (WST) stake by 8% in Q3 2026, buying an estimated $920K and bringing the position to 35,036 shares worth $13M. The position accounts for 0.03% of the portfolio, ranked #408.

Danske Bank first reported a position in WST in Q1 2024 and has held it in 11 quarters since. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Danske Bank held 35,036 shares of West Pharmaceutical worth $13M as of Q3 2026.
  • Danske Bank bought 2,607 West Pharmaceutical shares in Q3 2026, an estimated $920K.
  • West Pharmaceutical made up 0.03% of Danske Bank's portfolio in Q3 2026, its #408 holding.
  • Danske Bank first reported a position in West Pharmaceutical in Q1 2024 and has held it in 11 quarters since.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.